caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1053446260

Rachel SalitMD

PRACTICEFRED HUTCHINSON CANCER CENTERSee all providers at this practice →
Hematology-OncologySeattle, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 500138
Hospital
REFERRAL NETWORK

Where Rachel Salit's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
FRED HUTCHINSON CANCER CENTER304,066
UNIVERSITY OF WASHINGTON22214
Joseph Godwin
Diagnostic Radiology · Seattle, WA
1588
Jerald Radich
Medical Oncology · Seattle, WA
151,639
NPI 128571908811171
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
FRED HUTCHINSON CANCER CENTER333,852
UNIVERSITY OF WASHINGTON25170
Joseph Godwin
Diagnostic Radiology · Seattle, WA
19158
Sudhakar Pipavath
Diagnostic Radiology · Seattle, WA
1159
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
76
Unique beneficiaries
—
Total services
205
Distinct HCPCS
2
Medicare payment
$15K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 247 Hematology-Oncology providers in WA — bottom quintile (cohort median 770).
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
74.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
12
Beneficiaries
—
Total drug cost
$150
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Magnesium Sulfate12 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.